BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22541966)

  • 21. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.
    Wang H; Liao Z; Zhuang Y; Xu T; Nguyen QN; Levy LB; O'Reilly M; Gold KA; Gomez DR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1071-7. PubMed ID: 24161424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
    Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J
    Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of radiation pneumonitis risk using a generalized Lyman model.
    Tucker SL; Liu HH; Liao Z; Wei X; Wang S; Jin H; Komaki R; Martel MK; Mohan R
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):568-74. PubMed ID: 18793959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
    Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
    Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.
    Pang Q; Wei Q; Xu T; Yuan X; Lopez Guerra JL; Levy LB; Liu Z; Gomez DR; Zhuang Y; Wang LE; Mohan R; Komaki R; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1332-9. PubMed ID: 23374503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.
    Yin M; Liao Z; Huang YJ; Liu Z; Yuan X; Gomez D; Wang LE; Wei Q
    PLoS One; 2011; 6(5):e20055. PubMed ID: 21647442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Plasma Levels and Polymorphisms of Vitronectin Predict Radiation Pneumonitis in Patients With Lung Cancer Receiving Thoracic Radiation Therapy.
    Yu JH; Zhao QY; Liu Y; Zhu XR; Yang ZR; Fu XL; Cai XW
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):757-765. PubMed ID: 33610390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss.
    Selvaraj J; Lebesque J; Hope A; Guckenberger M; Werner-Wasik M; Peulen H; Giuliani M; Mantel F; Belderbos J; Grills I; Sonke JJ
    Radiother Oncol; 2019 Mar; 132():142-147. PubMed ID: 30825963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel method to incorporate the spatial location of the lung dose distribution into predictive radiation pneumonitis modeling.
    Vinogradskiy Y; Tucker SL; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1549-55. PubMed ID: 21741183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.
    Seppenwoolde Y; De Jaeger K; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):748-58. PubMed ID: 15465191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort.
    Tucker SL; Liao Z; Dinh J; Bian SX; Mohan R; Martel MK; Grosshans DR
    Acta Oncol; 2014 May; 53(5):590-6. PubMed ID: 23992110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.
    Mak RH; Alexander BM; Asomaning K; Heist RS; Liu CY; Su L; Zhai R; Ancukiewicz M; Napolitano B; Niemierko A; Willers H; Choi NC; Christiani DC
    Cancer; 2012 Jul; 118(14):3654-65. PubMed ID: 22144047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receiving radiotherapy: a retrospective multi-center radiogenomics study.
    Li J; Li L; Tang S; Yu Q; Liu W; Liu N; Yang F; Zhang D; Yuan S
    BMC Cancer; 2024 Jan; 24(1):78. PubMed ID: 38225543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the relationship between gross tumor volume location and pneumonitis rates using a large clinical database of non-small-cell lung cancer patients.
    Vinogradskiy Y; Tucker SL; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1650-8. PubMed ID: 21497454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.